Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system
Author:
Affiliation:
1. Tianjin Key Laboratory of Biomaterial Research
2. Institute of Biomedical Engineering
3. Chinese Academy of Medical Science and Peking Union Medical College
4. Tianjin 300192
5. China
Abstract
A ROS-triggered nanoparticle-based antigen delivery system that could be employed to promote in vivo efficacy of vaccine-induced immune responses.
Funder
Chinese Academy of Medical Sciences
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science
Link
http://pubs.rsc.org/en/content/articlepdf/2018/NR/C8NR00355F
Reference54 articles.
1. Recent advances in peptide-based subunit nanovaccines
2. Towards tailored vaccine delivery: Needs, challenges and perspectives
3. Silica Nanospheres: Hollow Structure Improved Anti-Cancer Immunity of Mesoporous Silica Nanospheres In Vivo (Small 26/2016)
4. Rod-shaped and fluorine-substituted hydroxyapatite free of molecular immunopotentiators stimulates anti-cancer immunity in vivo
5. Stimulation of In Vivo Antitumor Immunity with Hollow Mesoporous Silica Nanospheres
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. pH and ROS Responsiveness of Polymersome Nanovaccines for Antigen and Adjuvant Codelivery: An In Vitro and In Vivo Comparison;Biomacromolecules;2024-01-18
2. Recent progress in cancer immunotherapy: Application of nano-therapeutic systems;Journal of Drug Delivery Science and Technology;2024-01
3. Uptake Quantification of Antigen Carried by Nanoparticles and Its Impact on Carrier Adjuvanticity Evaluation;Vaccines;2023-12-26
4. PLGA-Encapsulated Haemonchus contortus Antigen ES-15 Augments Immune Responses in a Murine Model;Vaccines;2023-11-30
5. Facile preparation of PEGylated polyethylenimine polymers as vaccine carriers with reduced cytotoxicity and enhanced Interleukin-2 (IL-2) production;Colloids and Surfaces B: Biointerfaces;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3